Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2025-12-25 @ 1:04 PM
NCT ID: NCT01390259
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01390259
Study Brief: Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Adolescents Adolescents participated in both the Standard Control to Range (sCTR) Closed-Loop Control (CLC) Admission and the Open-Loop admission. Experimental: The CLC used a computer to make recommendations for their insulin treatment. This system was designed to both: 1. monitor the meal boluses of the patient and correct it in case of observed/predicted under insulinization (avoidance of prolonged hyperglycemia), based on a coarse and subjective knowledge of the meal amount, a precise understanding of the subject's day to day insulin treatment, continuous glucose monitoring, and past insulin injections; 2. predict and avoid hypoglycemic events, based on continuous glucose reading and past insulin injection. Placebo Comparator: Open Loop. The subjects were in charge of their insulin treatment. None None 0 11 0 11 View
Serious Events(If Any):
Other Events(If Any):